dialysis associated hypotention. Kidney dialysis?Hypotension
Conditions
Interventions
Intervention 1: treatment group:administration tablet of sertraline 50-100mg once daily for 8 weeks. Intervention 2: control group:administration placebo of sertralin50-100mg once daily for 8 weeks.
Treatment - Drugs
treatment group:administration tablet of sertraline 50-100mg once daily for 8 weeks
control group:administration placebo of sertralin50-100mg once daily for 8 weeks
Sponsors
Tehran University of Medical Science and Health Services
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion:patient suffer from dialysis associated hypotention exclusion:systolic dysfunction,patients who can not tolerate sertraline's adverse effect,refusal to participate in the study,usage of midodrin
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hypotention. Timepoint: 4weeks before intervention,during intervention,4weeks after intervention. Method of measurement: mmhg with use of digital barometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications of hypotention such as cramp,dizziness,headache,neusea and vomiting,. Timepoint: 4weeks before intervention,during intervention,4weeks after intervention. Method of measurement: observation. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed